Articles with "mfolfoxiri without" as a keyword



Photo by finnnyc from unsplash

mFOLFOXIRI with or without cetuximab as conversion therapy in patients with RAS/BRAF wild-type unresectable liver metastases colorectal cancer: The FOCULM study.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.4_suppl.99

Abstract: 99Background: Conversion therapy for unresectable colorectal liver metastases (LM) can downsize tumours and create a situation where the patient has no evidence of disease (NED). We assessed the ef... read more here.

Keywords: liver metastases; conversion therapy; mfolfoxiri without;